Interventional Cardiology
Advertisement
Dr. Amit Goyal details a study which explored the role of coronary sinus reducer in Coronary microvascular dysfunction.
The possibility of DCBs to rescue side branches during provisional coronary bifurcation stenting is appealing.
Dr. Amit Goyal details the first-in-human study of the Magenta Elevate system.
Mayo Clinic researchers identified a new approach to treating infective endocarditis using a catheter-based method.
Results of the EARLY TAVR trial introduced a potential paradigm shift in managing asymptomatic high-gradient severe AS.
Two pivotal trials—EARLY TAVR and EVOLVED—were presented, each exploring early intervention in asymptomatic severe AS.
ECLIPSE investigated whether OA provides better outcomes than conventional balloon angioplasty in calcified coronary lesions.
An analysis of PROTECTED TAVR trial highlighted potential regional differences in the efficacy of CEP during TAVR.
Sirolimus-coated balloons are non-inferior to paclitaxel-coated balloons in patients with femoropopliteal artery disease.
Black patients are 22% more likely to die than White patients following coronary artery bypass grafting surgery.
Researchers have developed a novel blood test that can diagnose a heart attack within minutes.
A study demonstrated long-term safety and efficacy of the GORE CARDIOFORM ASD Occluder.
The RESHAPE-HF2 trial offers further insights into the transcatheter management of patients with HFrEF and FMR.
The SENIOR-RITA trial investigates the optimal management strategy for older adults with NSTEMI.
The SCOFF trial challenges the long-standing practice of fasting before cardiac catheterization procedures.
PVI results in clinically important improvements in both symptom burden and quality of life compared with a placebo.
The NOTION 3 trial contributes important data to the ongoing debate about the role of PCI before TAVI in patients with CAD.
Clinical follow-up using AI-generated technology can help identify complications in patients following TAVI.
While transvenous pacemakers have been the standard, the emergence of leadless pacemakers offers a promising alternative,
The risk of early heart failure following heart transplantation is lower with so-called "heart-in-a-box" storage.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.